CME Group reported Q2 2026 EPS of $2.99 and revenue of $1.71B, topping analysts’ expectations, while Market Data revenue rose more than 20% YoY. Despite this operational strength, the stock is down nearly 12% over the past 11 months versus the S&P 500. Overall, results suggest improving fundamentals and likely support near-term sentiment.
CME Group reported Q2 2026 EPS of $2.99 and revenue of $1.71B, topping analysts’ expectations, while Market Data revenue rose more than 20% YoY. Despite this operational strength, the stock is down nearly 12% over the past 11 months versus the S&P 500. Overall, results suggest improving fundamentals and likely support near-term sentiment.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
